tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

JNJJohnson & Johnson

Health care · Pharmaceuticals · NYSE

Johnson & Johnson and its subsidiaries (the Company) have approximately 138,200 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. 10-K, Item 1

Headquarters
New Brunswick, NJ
CEO
Joaquin Duato
Next results
around Jan 20, 2027
Compare with peers → Embed
This is a calculator, not a valuation. It answers one question: how fast would free cash flow have to grow for the share price to make sense, with the assumptions you choose. Tickdelta does not estimate what JNJ is worth.

From the filings and the price source

Your assumptions

Type a share price to see what it implies.
JNJ's free cash flow, last 5 years-0.5% a year
Revenue, last 5 years+2.7% a year
Free cash flow, longest history (10 years)+2.7% a year

Past growth is from the 10-Ks (see the Financials tab). It is there to compare against, not to predict.

Implied growth for other assumptions

Model: free cash flow grows at the implied rate for the chosen years, then at the forever rate. Each year is discounted at your rate, and debt minus cash is subtracted. Change any number above and everything recalculates. Not advice.

Work on JNJ in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/JNJ/export.csv") into a cell.